Aprinoia Therapeutics (Aprinoia Therapeutics) Ending Cash Position : $7.73 Mil (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Ending Cash Position?

Aprinoia Therapeutics's Ending Cash Position for the quarter that ended in Jun. 2023 was $7.73 Mil.

Aprinoia Therapeutics's quarterly Ending Cash Position declined from Jun. 2022 ($7.69 Mil) to Dec. 2022 ($1.22 Mil) but then increased from Dec. 2022 ($1.22 Mil) to Jun. 2023 ($7.73 Mil).

Aprinoia Therapeutics's annual Ending Cash Position increased from . 20 ($0.00 Mil) to Dec. 2021 ($9.67 Mil) but then declined from Dec. 2021 ($9.67 Mil) to Dec. 2022 ($1.22 Mil).

Aprinoia Therapeutics Ending Cash Position Historical Data

The historical data trend for Aprinoia Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Ending Cash Position Chart

Aprinoia Therapeutics Annual Data

Trend

Dec21

Dec22

Ending Cash Position

9.67

1.22

Aprinoia Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23
Ending Cash Position	-	7.69	1.22	7.73

Aprinoia Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Aprinoia Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	9.674	+	-8.453
	=	1.22

Aprinoia Therapeutics's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.221	+	6.51
	=	7.73

Aprinoia Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Aprinoia Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines